Bliss GVS Pharma Limited
NSE:BLISSGVS.NS
124.26 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 7,702.449 | 7,515.875 | 7,379.285 | 5,686.875 | 6,819.1 | 8,861.094 | 3,638.245 | 7,997.409 | 5,468.941 | 4,071.344 | 3,468.684 | 3,966.254 | 2,666.749 | 2,188.381 | 1,688.753 | 1,329.557 | 1,023.959 | 623.392 |
Cost of Revenue
| 5,040.799 | 4,013.249 | 3,909.82 | 3,289.09 | 4,399.734 | 6,122.565 | 1,942.297 | 3,593.41 | 2,567.653 | 1,775.465 | 1,706.307 | 2,038.097 | 1,574.717 | 1,273.943 | 905.725 | 698.406 | 445.944 | 356.586 |
Gross Profit
| 2,661.65 | 3,502.626 | 3,469.465 | 2,397.785 | 2,419.366 | 2,738.529 | 1,695.948 | 4,403.999 | 2,901.288 | 2,295.879 | 1,762.377 | 1,928.157 | 1,092.032 | 914.438 | 783.028 | 631.151 | 578.015 | 266.806 |
Gross Profit Ratio
| 0.346 | 0.466 | 0.47 | 0.422 | 0.355 | 0.309 | 0.466 | 0.551 | 0.531 | 0.564 | 0.508 | 0.486 | 0.409 | 0.418 | 0.464 | 0.475 | 0.564 | 0.428 |
Reseach & Development Expenses
| 152.297 | 217.888 | 213.796 | 104.007 | 76.887 | 142.578 | 25.104 | 36.81 | 32.087 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 84.076 | 72.765 | 88.751 | 69.695 | 60.435 | 72.19 | 43.281 | 410.781 | 574.392 | 410.382 | 47.357 | 45.635 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 346.806 | 421.652 | 451.776 | 209.511 | 211.374 | 204.689 | 153.24 | 212.683 | 318.507 | 353.487 | 351.168 | 402.602 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 1,419.222 | 494.417 | 540.527 | 279.206 | 271.809 | 276.879 | 196.521 | 623.464 | 892.899 | 763.869 | 828.432 | 658.943 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 287.374 | 177.864 | 25.483 | 27.41 | 14.628 | 5.712 | 88.833 | 19.747 | 26.771 | 26.773 | 5.583 | 2.902 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 1,419.222 | 2,516.134 | 2,288.721 | 1,487.819 | 1,282.861 | 1,140.259 | 812.566 | 2,668.527 | 1,386.631 | 1,374.449 | 1,134.73 | 874.675 | 257.534 | 363.15 | 305.036 | 205.997 | 211.863 | 201.506 |
Operating Income
| 1,242.428 | 986.492 | 1,013.157 | 894.471 | 1,111.466 | 1,510.689 | 1,064.863 | 1,915.83 | 1,732.788 | 1,114.094 | 627.647 | 1,045.772 | 834.498 | 551.287 | 477.993 | 425.154 | 366.153 | 65.3 |
Operating Income Ratio
| 0.161 | 0.131 | 0.137 | 0.157 | 0.163 | 0.17 | 0.293 | 0.24 | 0.317 | 0.274 | 0.181 | 0.264 | 0.313 | 0.252 | 0.283 | 0.32 | 0.358 | 0.105 |
Total Other Income Expenses Net
| -73.708 | 74.224 | -471.504 | 146.799 | 178.184 | 308.463 | -424.92 | -124.039 | -250.841 | -153.902 | 77.935 | 49.052 | -40.305 | -21.473 | -20.441 | -22.619 | -13.834 | -6.663 |
Income Before Tax
| 1,168.72 | 1,060.716 | 541.653 | 1,041.27 | 1,289.651 | 1,819.131 | 639.943 | 1,791.791 | 1,481.947 | 960.192 | 705.582 | 1,094.824 | 794.193 | 529.814 | 457.552 | 402.535 | 352.319 | 58.637 |
Income Before Tax Ratio
| 0.152 | 0.141 | 0.073 | 0.183 | 0.189 | 0.205 | 0.176 | 0.224 | 0.271 | 0.236 | 0.203 | 0.276 | 0.298 | 0.242 | 0.271 | 0.303 | 0.344 | 0.094 |
Income Tax Expense
| 352.941 | 291.542 | 310.388 | 301.554 | 337.123 | 552.504 | 322.693 | 628.409 | 480.491 | 346.258 | 295.267 | 498.978 | 268.835 | 123.511 | 40.337 | 28.023 | 14.966 | 20.228 |
Net Income
| 754.541 | 708.588 | 150.402 | 684.909 | 972.65 | 1,237.216 | 587.853 | 856.106 | 824.826 | 599.097 | 409.917 | 577.201 | 525.358 | 406.303 | 417.215 | 374.512 | 337.353 | 38.409 |
Net Income Ratio
| 0.098 | 0.094 | 0.02 | 0.12 | 0.143 | 0.14 | 0.162 | 0.107 | 0.151 | 0.147 | 0.118 | 0.146 | 0.197 | 0.186 | 0.247 | 0.282 | 0.329 | 0.062 |
EPS
| 7.23 | 6.83 | 1.46 | 6.64 | 9.43 | 11.99 | 5.7 | 7.95 | 8 | 5.81 | 3.97 | 5.6 | 5.09 | 3.94 | 4.04 | 3.63 | 2.04 | 6.53 |
EPS Diluted
| 7.11 | 6.72 | 1.43 | 6.49 | 9.43 | 11.99 | 5.7 | 7.95 | 8 | 5.81 | 3.97 | 5.6 | 5.09 | 3.94 | 4.04 | 3.63 | 2.04 | 6.53 |
EBITDA
| 1,506.226 | 1,351.089 | 1,650.162 | 1,272.187 | 1,619.674 | 2,059.296 | 1,278.692 | 2,121.341 | 1,875.299 | 1,236.966 | 739.72 | 1,107.016 | 870.959 | 605.982 | 532.004 | 461.068 | 395.419 | 94.47 |
EBITDA Ratio
| 0.196 | 0.18 | 0.224 | 0.224 | 0.238 | 0.232 | 0.351 | 0.265 | 0.343 | 0.304 | 0.213 | 0.279 | 0.327 | 0.277 | 0.315 | 0.347 | 0.386 | 0.152 |